습윤 상처 드레싱 시장 : 제품별, 용도별, 최종사용자별, 지역별(2025-2033년)

The global moist wound dressings market size reached USD 5.2 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 7.7 Billion by 2033, exhibiting a growth rate (CAGR) of 4.19% during 2025-2033. The rising awareness among healthcare professionals, patients, and caregivers, the widespread adoption of medical products and treatments due to reimbursement policies, and the advancements in surgical techniques are some of the major factors propelling the market.

Moist wound dressings are a type of advanced wound care solution that fosters a moist environment to facilitate faster, more effective healing. These dressings can retain or donate moisture to the wound bed, encouraging natural healing processes, including autolytic debridement and cell proliferation. They're comprised of materials such as alginates, hydrocolloids, hydrogels, or foams, and they come in various forms including gels, creams, films, and more. By keeping the wound moist, these dressings aid in the reduction of scarring and tissue damage, reduce pain, and prevent the wound from drying out and forming a scab, which can delay healing. Moist wound dressings also assist in protecting the wound from infection and absorbing exudate, making them ideal for chronic wounds, surgical wounds, burns, and ulcers. Therefore, moist wound dressings play a crucial role in promoting optimal wound healing conditions.

Healthcare expenditure continues to rise due to factors such as population growth, increasing life expectancy, and the prevalence of chronic diseases. As healthcare spending increases, there is a greater allocation of resources toward wound care management. In addition, the rising awareness among healthcare professionals, patients, and caregivers regarding the benefits of moist wound dressings. Educational initiatives, training programs, and awareness campaigns conducted by healthcare organizations and wound care associations have played a significant role in disseminating knowledge about the advantages of moist dressings. Apart from this, reimbursement policies and insurance coverage significantly impact the adoption of medical products and treatments. Favorable reimbursement policies for moist wound dressings encourage healthcare providers to prescribe and utilize these products. Furthermore, advancements in surgical techniques and a shift towards minimally invasive procedures contribute to the demand for moist dressings, as they are compatible with these approaches. The increasing volume of surgical procedures drives the market growth for moist wound dressings.

Moist Wound Dressings Market Trends/Drivers:

Increasing Prevalence of Chronic Wounds

Chronic wounds, such as pressure ulcers, diabetic foot ulcers, and venous leg ulcers, have become a significant healthcare challenge worldwide. Along with this, the aging population, rising incidence of diabetes, and a growing number of individuals with limited mobility contribute to the increasing prevalence of chronic wounds. Moist wound dressings have gained prominence as an effective treatment option for managing chronic wounds due to their ability to create an optimal healing environment. These dressings maintain a moist environment, facilitate wound debridement, and enhance the wound healing process by promoting granulation tissue formation. The expanding patient pool with chronic wounds is expected to drive the demand for moist wound dressings in the market.

Growing Emphasis on Cost-effective Wound Management

In recent years, healthcare systems across the globe have been striving to contain costs while delivering quality care. As a result, there is a growing emphasis on cost-effective wound management solutions. Moist wound dressings are gaining popularity due to their cost-effectiveness compared to traditional wound care methods, such as gauze dressings. Moist dressings require fewer changes, minimize the risk of wound contamination, and reduce the need for additional treatments, resulting in overall cost savings. Additionally, moist wound dressings offer improved patient comfort and convenience, leading to better compliance with treatment regimens. The cost-effectiveness and potential savings associated with moist wound dressings are expected to drive their adoption in healthcare settings.

Technological Advancements in Moist Wound Dressings

The market for moist wound dressings is experiencing continuous innovation and technological advancements. Manufacturers are focusing on developing advanced dressings that offer superior moisture management, enhanced breathability, improved exudate absorption, and prolonged wear time. Advanced dressing materials such as hydrogels, foams, films, and alginates are being incorporated into moist wound dressings to provide better wound-healing outcomes. Moreover, the integration of antimicrobial agents into dressings helps combat wound infections. Technological advancements in moist wound dressings not only improve patient comfort and compliance but also contribute to better healing rates. As healthcare professionals and patients become aware of these advanced products, the demand for moist wound dressings is contributing to the market.

Moist Wound Dressings Industry Segmentation:

Product Insights:

• Foam Dressings
• Hydrocolloid Dressings
• Film Dressings
• Alginate Dressings
• Hydrogel Dressings
• Collagen Dressings
• Others
• Foam dressings dominate the market
• Foam dressings have emerged as a popular product in the moist wound dressings industry, and their market growth is driven by several factors. Additionally, foam dressings offer excellent absorption capabilities, effectively managing moderate to heavily exuding wounds. The ability to absorb and lock away excess wound fluid reduces the risk of maceration and promotes a moist wound environment conducive to healing. In addition, foam dressings provide a cushioning effect, protecting the wound from external trauma and minimizing pain. This feature makes them particularly suitable for pressure ulcers, surgical wounds, and other injuries requiring extra protection. Furthermore, foam dressings are highly versatile, easily conforming to wound contours, and can be used on both shallow and deep wounds. Furthermore, advancements in foam dressing technology, such as the incorporation of silver or other antimicrobial agents, further enhance their efficacy in preventing and managing wound infections.

Application Insights:

• Acute Wounds
• Surgical and Traumatic Wounds
• Burns
• Chronic Wounds
• Diabetic Foot Ulcers
• Pressure Ulcers
• Venous Leg Ulcers
• Others
• Chronic wounds hold the largest share in the market
• The application of moist wound dressings in the management of chronic wounds is driven by the increasing prevalence of chronic wounds, including pressure ulcers, diabetic foot ulcers, and venous leg ulcers, which is a significant driver. The aging population, rising incidence of diabetes, and lifestyle factors contribute to the growing burden of chronic wounds, necessitating effective treatment options. Moist wound dressings create an optimal healing environment, promoting granulation tissue formation and facilitating the wound healing process. In addition, the technological advancements in moist wound dressings specifically tailored for chronic wounds fuel their market growth. These advancements include dressings with enhanced moisture management, improved exudate absorption, and prolonged wear time, all of which contribute to better healing outcomes. Moreover, the emphasis on cost-effective wound management is a crucial driver for moist wound dressings in chronic wound applications.

End User Insights:

• Hospitals
• Specialty Clinics
• Homecare
• Others
• Hospitals dominate the market
• The application of moist wound dressings in hospitals is driven by the escalating number of patients with acute and chronic wounds. The rising demand for moist wound dressings in hospitals is due to the need to provide effective wound care and promote optimal healing outcomes. Along with this, hospitals strive to enhance patient comfort and satisfaction while delivering quality care. Moist wound dressings offer advantages such as improved pain management, reduced risk of infection, and enhanced wound healing, which contribute to better patient experiences. Moreover, hospitals focus on infection control and prevention, and moist dressings with antimicrobial properties help address this concern by minimizing the risk of wound infections. Additionally, it helps maintain an ideal moisture balance in the wound bed, which is crucial for promoting healing. It can either retain moisture in dry wounds or absorb excess moisture in heavily exuding wounds, ensuring the right level of moisture for optimal healing.

Regional Insights:

• North America
• United States
• Canada
• Asia-Pacific
• China
• Japan
• India
• South Korea
• Australia
• Indonesia
• Others
• Europe
• Germany
• France
• United Kingdom
• Italy
• Spain
• Russia
• Others
• Latin America
• Brazil
• Mexico
• Others
• Middle East and Africa
• North America exhibits a clear dominance, accounting for the largest moist wound dressings market share
• The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.
• The moist wound dressings industry in North America is driven by several market drivers. The region has a high prevalence of chronic diseases such as diabetes, obesity, and cardiovascular conditions, which contribute to the increasing incidence of chronic wounds. Along with this, the growing aging population in North America further fuels the demand for moist wound dressings as this demographic is more prone to chronic wounds. In addition, North America has a well-established healthcare infrastructure with advanced wound care facilities and a strong emphasis on quality patient care. Healthcare providers in the region recognize the benefits of moist wound dressings in promoting faster healing, reducing complications, and improving patient outcomes. Furthermore, technological advancements and innovations in the field of wound care are prevalent in North America.

Competitive Landscape:

• The global moist wound dressings market is experiencing significant growth due to the development of advanced products to offer better wound care solutions. This includes hydrogels, hydrocolloids, alginates, and foam dressings that promote moist wound healing. Along with this, the escalating number of partnerships and collaborations to enhance research and development efforts, expand geographical reach, or combine resources and expertise to create new products is significantly supporting the market. In addition, companies are providing training and educational resources for healthcare professionals and patients to understand the advantages of moist wound healing, significantly supporting the marketing. With the rise of digital health and telemedicine, some companies are working on integrating their products with digital health platforms to enhance patient monitoring and care.

The report has provided a comprehensive analysis of the competitive landscape in the global moist wound dressings market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

• 3M Company
• Advanced Medical Solutions Group plc
• B. Braun Medical Inc.
• Cardinal Health Inc.
• Coloplast A/S
• Convatec Inc.
• Hartmann AG
• Hollister Incorporated
• Lohmann & Rauscher
• Medline Industries Inc.
• Molnlycke Health Care AB
• Scapa Group Limited
• Smith & Nephew Plc

Key Questions Answered in This Report:

• How has the global moist wound dressings market performed so far, and how will it perform in the coming years?
• What are the drivers, restraints, and opportunities in the global moist wound dressings market?
• What is the impact of each driver, restraint, and opportunity on the global moist wound dressings market?
• What are the key regional markets?
• Which countries represent the most attractive moist wound dressings market?
• What is the breakup of the market based on the product?
• Which is the most attractive product in the moist wound dressings market?
• What is the breakup of the market based on the application?
• Which is the most attractive application in the moist wound dressings market?
• What is the breakup of the market based on the end user?
• Which is the most attractive end user in the moist wound dressings market?
• What is the competitive structure of the global moist wound dressings market?
• Who are the key players/companies in the global moist wound dressings market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Moist Wound Dressings Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Forecast

6 Market Breakup by Product

• 6.1 Foam Dressings
  • 6.1.1 Market Trends
  • 6.1.2 Market Forecast
• 6.2 Hydrocolloid Dressings
  • 6.2.1 Market Trends
  • 6.2.2 Market Forecast
• 6.3 Film Dressings
  • 6.3.1 Market Trends
  • 6.3.2 Market Forecast
• 6.4 Alginate Dressings
  • 6.4.1 Market Trends
  • 6.4.2 Market Forecast
• 6.5 Hydrogel Dressings
  • 6.5.1 Market Trends
  • 6.5.2 Market Forecast
• 6.6 Collagen Dressings
  • 6.6.1 Market Trends
  • 6.6.2 Market Forecast
• 6.7 Others
  • 6.7.1 Market Trends
  • 6.7.2 Market Forecast

7 Market Breakup by Application

• 7.1 Acute Wounds
  • 7.1.1 Market Trends
  • 7.1.2 Key Segments
    • 7.1.2.1 Surgical and Traumatic Wounds
    • 7.1.2.2 Burns
  • 7.1.3 Market Forecast
• 7.2 Chronic Wounds
  • 7.2.1 Market Trends
  • 7.2.2 Key Segments
    • 7.2.2.1 Diabetic Foot Ulcers
    • 7.2.2.2 Pressure Ulcers
    • 7.2.2.3 Venous Leg Ulcers
    • 7.2.2.4 Others
  • 7.2.3 Market Forecast

8 Market Breakup by End User

• 8.1 Hospitals
  • 8.1.1 Market Trends
  • 8.1.2 Market Forecast
• 8.2 Specialty Clinics
  • 8.2.1 Market Trends
  • 8.2.2 Market Forecast
• 8.3 Homecare
  • 8.3.1 Market Trends
  • 8.3.2 Market Forecast
• 8.4 Others
  • 8.4.1 Market Trends
  • 8.4.2 Market Forecast

9 Market Breakup by Region

• 9.1 North America
  • 9.1.1 United States
    • 9.1.1.1 Market Trends
    • 9.1.1.2 Market Forecast
  • 9.1.2 Canada
    • 9.1.2.1 Market Trends
    • 9.1.2.2 Market Forecast
• 9.2 Asia-Pacific
  • 9.2.1 China
    • 9.2.1.1 Market Trends
    • 9.2.1.2 Market Forecast
  • 9.2.2 Japan
    • 9.2.2.1 Market Trends
    • 9.2.2.2 Market Forecast
  • 9.2.3 India
    • 9.2.3.1 Market Trends
    • 9.2.3.2 Market Forecast
  • 9.2.4 South Korea
    • 9.2.4.1 Market Trends
    • 9.2.4.2 Market Forecast
  • 9.2.5 Australia
    • 9.2.5.1 Market Trends
    • 9.2.5.2 Market Forecast
  • 9.2.6 Indonesia
    • 9.2.6.1 Market Trends
    • 9.2.6.2 Market Forecast
  • 9.2.7 Others
    • 9.2.7.1 Market Trends
    • 9.2.7.2 Market Forecast
• 9.3 Europe
  • 9.3.1 Germany
    • 9.3.1.1 Market Trends
    • 9.3.1.2 Market Forecast
  • 9.3.2 France
    • 9.3.2.1 Market Trends
    • 9.3.2.2 Market Forecast
  • 9.3.3 United Kingdom
    • 9.3.3.1 Market Trends
    • 9.3.3.2 Market Forecast
  • 9.3.4 Italy
    • 9.3.4.1 Market Trends
    • 9.3.4.2 Market Forecast
  • 9.3.5 Spain
    • 9.3.5.1 Market Trends
    • 9.3.5.2 Market Forecast
  • 9.3.6 Russia
    • 9.3.6.1 Market Trends
    • 9.3.6.2 Market Forecast
  • 9.3.7 Others
    • 9.3.7.1 Market Trends
    • 9.3.7.2 Market Forecast
• 9.4 Latin America
  • 9.4.1 Brazil
    • 9.4.1.1 Market Trends
    • 9.4.1.2 Market Forecast
  • 9.4.2 Mexico
    • 9.4.2.1 Market Trends
    • 9.4.2.2 Market Forecast
  • 9.4.3 Others
    • 9.4.3.1 Market Trends
    • 9.4.3.2 Market Forecast
• 9.5 Middle East and Africa
  • 9.5.1 Market Trends
  • 9.5.2 Market Breakup by Country
  • 9.5.3 Market Forecast

10 Drivers, Restraints, and Opportunities

• 10.1 Overview
• 10.2 Drivers
• 10.3 Restraints
• 10.4 Opportunities

11 Value Chain Analysis

12 Porters Five Forces Analysis

• 12.1 Overview
• 12.2 Bargaining Power of Buyers
• 12.3 Bargaining Power of Suppliers
• 12.4 Degree of Competition
• 12.5 Threat of New Entrants
• 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

• 14.1 Market Structure
• 14.2 Key Players
• 14.3 Profiles of Key Players
  • 14.3.1 3M Company
    • 14.3.1.1 Company Overview
    • 14.3.1.2 Product Portfolio
    • 14.3.1.3 Financials
    • 14.3.1.4 SWOT Analysis
  • 14.3.2 Advanced Medical Solutions Group plc
    • 14.3.2.1 Company Overview
    • 14.3.2.2 Product Portfolio
    • 14.3.2.3 Financials
    • 14.3.2.4 SWOT Analysis
  • 14.3.3 B. Braun Medical Inc.
    • 14.3.3.1 Company Overview
    • 14.3.3.2 Product Portfolio
  • 14.3.4 Cardinal Health Inc.
    • 14.3.4.1 Company Overview
    • 14.3.4.2 Product Portfolio
    • 14.3.4.3 Financials
    • 14.3.4.4 SWOT Analysis
  • 14.3.5 Coloplast A/S
    • 14.3.5.1 Company Overview
    • 14.3.5.2 Product Portfolio
    • 14.3.5.3 Financials
    • 14.3.5.4 SWOT Analysis
  • 14.3.6 Convatec Inc.
    • 14.3.6.1 Company Overview
    • 14.3.6.2 Product Portfolio
    • 14.3.6.3 Financials
  • 14.3.7 Hartmann AG
    • 14.3.7.1 Company Overview
    • 14.3.7.2 Product Portfolio
  • 14.3.8 Hollister Incorporated
    • 14.3.8.1 Company Overview
    • 14.3.8.2 Product Portfolio
    • 14.3.8.3 SWOT Analysis
  • 14.3.9 Lohmann & Rauscher
    • 14.3.9.1 Company Overview
    • 14.3.9.2 Product Portfolio
  • 14.3.10 Medline Industries Inc.
    • 14.3.10.1 Company Overview
    • 14.3.10.2 Product Portfolio
    • 14.3.10.3 SWOT Analysis
  • 14.3.11 Molnlycke Health Care AB
    • 14.3.11.1 Company Overview
    • 14.3.11.2 Product Portfolio
    • 14.3.11.3 Financials
  • 14.3.12 Scapa Group Limited
    • 14.3.12.1 Company Overview
    • 14.3.12.2 Product Portfolio
    • 14.3.12.3 SWOT Analysis
  • 14.3.13 Smith & Nephew Plc
    • 14.3.13.1 Company Overview
    • 14.3.13.2 Product Portfolio
    • 14.3.13.3 Financials
    • 14.3.13.4 SWOT Analysis

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.